U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

PARSACLISIB

MORE DETAILS

OS7097575K

Status:
Investigational
Source:
NCT04434937: Phase 2 Interventional Completed Lymphoma
(2020)
Source URL:
https://clinicaltrials.gov/ct2/show/NCT04434937
Class (Stereo):
CHEMICAL (ABSOLUTE)

PARSACLISIB HYDROCHLORIDE

MORE DETAILS

S0GJ8VM4P9

Status:
Investigational
Source:
NCT04434937: Phase 2 Interventional Completed Lymphoma
(2020)
Source URL:
https://clinicaltrials.gov/ct2/show/NCT04434937
Class (Stereo):
CHEMICAL (ABSOLUTE)
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966